290
Views
143
CrossRef citations to date
0
Altmetric
Original Research

Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light

, , , , , & show all
Pages 2705-2714 | Published online: 03 Nov 2011

References

  • World Health OrganizationLeishmaniasis Available from: http://www.who.int/leishmaniasis/en/Accessed January 16, 2010
  • DesjeuxPLeishmaniasis: current situation and new perspectivesComp Immunol Microbiol Infect Dis200427530531815225981
  • PetersonATShawJLutzomyia vectors for cutaneous leishmaniasis in Southern Brazil: ecological niche models, predicted geographic distributions, and climate change effectsInt J Parasitol200333991993112906876
  • HemmerCJFrimmelSKinzelbachRGürtlerLReisingerECGlobal warming: trailblazer for tropical infections in Germany?Dtsch Med Wochenschr20071324825832589 German18033654
  • BermanJDChemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategiesRev Infect Dis19881035605863293160
  • CroftSLRecent development in the chemotherapy of leishmaniasisTrends Pharmacol Sci19889103763813078072
  • HerwaldtBLBermanJDRecommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studiesAm J Trop Med Hyg19924632963061313656
  • AronsonNEWortmannGWJohnsonSCSafety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US military experienceClin Infect Dis1998276145714649868660
  • SeatonRAMorrisonJManIWatsonJNathwaniDOut-patient parenteral antimicrobial therapy: a viable option for the management of cutaneous leishmaniasisQJM1999921165966710542306
  • NateraSMachucaCPadrón-NievesMRomeroADiazEPonte-SucreALeishmania spp: proficiency of drug-resistant parasitesInt J Antimicrob Agents200729663764217353113
  • CroftSLCoombsGHLeishmaniasis: current chemotherapy and recent advances in the search for novel drugsTrends Parasitol2003191150250814580961
  • OuelletteMDrummelsmithJPapadopoulouBLeishmaniasis: drugs in the clinic, resistance and new developmentsDrug Resist Updat200474–525726615533763
  • SundarSRaiMChakravartyJNew treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosineClin Infect Dis20084781000100618781879
  • CurtisAWilkinsonCNantotechniques and approaches in biotechnologyTrends Biotechnol20011939710111179802
  • AngeliEBuzioRFirpoGNanotechnology applications in medicineTumori200894220621518564609
  • SwaiHSemeteBKalomboLChelulePKisichKSieversBNanomedicine for respiratory diseasesWiley Interdiscip Rev Nanomed Nanobiotechnol20091325526320049795
  • DebbagePTargeted drugs and nanomedicine: present and futureCurr Pharm Des200915215317219149610
  • ElechiguerraJLBurtJLMoronesJRInteraction of silver nanoparticles with HIV-1J Nanobiotechnology20053615987516
  • TokumaruTShimizuYFoxCLJrAntiviral activities of silver sulfadiazine and ocular infectionRes Commun Chem Pathol Pharmacol1974811511584368031
  • OkaHTomiokaTTomitaKNishinoAUedaSInactivation of enveloped viruses by a silver-thiosulfate complexMet Based Drugs199415–651118476269
  • OloffsAGrosse-SiestrupCBissonSRinckMRudolphRGrossUBiocompatibility of silver-coated polyurethane catheters and silver-coated Dacron materialBiomaterials199415107537587986938
  • ChopraIThe increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?J Antimicrob Chemother200759458759017307768
  • SondiISalopek-SondiBSilver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteriaJ Colloid Interface Sci2004275117718215158396
  • LiPLiJWuCWuQLiJSynergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticlesNanotechnology20051619121917
  • ShrivastavaSBeraTRoyASinghGRamachandraraoPDashDCharacterization of enhanced antibacterial effects of novel silver nanoparticlesNanotechnology20071819
  • PalSTakYKSongJMDoes the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coliAppl Environ Microbiol20077361712172017261510
  • LuLSunRWChenRSilver nanoparticles inhibit hepatitis B virus replicationAntivir Ther200813225326218505176
  • LaraHHAyala-NunezNVIxtepan-TurrentLRodriguez-PadillaCMode of antiviral action of silver nanoparticles against HIV-1J Nanobiotechnology20108120145735
  • ChoiOHuZSize dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteriaEnviron Sci Technol200842124583458818605590
  • MurrayHWSusceptibility of Leishmania to oxygen intermediates and killing by normal macrophagesJ Exp Med19811535130213157252418
  • LodgeRDescoteauxAPhagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activationEur J Immunol200636102735274416955522
  • MehtaAShahaCMechanism of metalloid-induced death in Leishmania spp: role of iron, reactive oxygen species, Ca2+, and glutathioneFree Radic Biol Med200640101857186816678023
  • ButkusMALabareMPStarkeJAMoonKTalbotMUse of aqueous silver to enhance inactivation of coliphage MS-2 by UV disinfectionAppl Environ Microbiol20047052848285315128542
  • ZhengJWuXWangMRanDXuWYangJStudy on the interaction between silver nanoparticles and nucleic acids in the presence of cetyltrimethylammonium bromide and its analytical applicationTalanta200874452653218371671
  • XiaTKovochichMBrantJComparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigmNano Lett2006681794180716895376
  • AshaRaniPVLowKahMunGHandeMPValiyaveettilSCytotoxicity and genotoxicity of silver nanoparticles in human cellsACS Nano20093227929019236062
  • SongHYKoKKOhIHLeeBTFabrication of silver nanoparticles and their antimicrobial mechanismsEur Cell Mater200611Suppl 158
  • FengQLWuJChenGQCuiFZKimTNKimJOA mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureusJ Biomed Mater Res200052466266811033548
  • SambhyVMacBrideMMPetersonBRSenASilver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materialsJ Am Chem Soc2006128309798980816866536
  • RatteHTBioaccumulation and toxicity of silver compounds: a reviewEnviron Toxicol Chem199918189108
  • BraggPDRainnieDJThe effect of silver ions on the respiratory chain of Escherichia coliCan J Microbiol19742068838894151872
  • LiauSYReadDCPughWJFurrJRRussellADInteraction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ionsLett Appl Microbiol19972542792839351278
  • MatsumuraYYoshikataKKunisakiSTsuchidoTMode of bactericidal action of silver zeolite and its comparison with that of silver nitrateAppl Environ Microbiol20036974278428112839814
  • RussellADHugoWBAntimicrobial activity and action of silverProg Med Chem1994313513708029478
  • ThurmanRBGerbaCPBittonGThe molecular mechanisms of copper and silver ion disinfection of bacteria and virusesCRC Crit Rev Environ Contr1989184295315
  • KimJYLeeCChoMYoonJEnhanced inactivation of E. coli and MS-2 phage by silver ions combined with UV-A and visible light irradiationWater Res2008421–235636217692890
  • TsuangYHSunJSHuangYCLuCHChangWHWangCCStudies of photokilling of bacteria using titanium dioxide nanoparticlesArtif Organs200832216717418269355
  • LiuPDuanWWangQLiXThe damage of outer membrane of Escherichia coli in the presence of TiO2 combined with UV lightColloids Surf B Biointerfaces201078217117620335010